Figure 3.
ALA/SFC reduces blood glucose and HbA1c levels in ZDF rats. The ZDF rats were orally administered ALA/SFC or pioglitazone for 6 weeks. (A) Plasma glucose levels. (B) HbA1c levels. *P < 0.05, **P < 0.01, ***P < 0.001 vs the vehicle‐administered group (Tukey's test, n = 8).